Product Information
DOXEPIN 50 MG CAPSULE is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.1463 per EA under NDC 72205009091. Its NADAC has been published 154 times since Jul 19, 2023.
Strength
50 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205009091
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215113On Market Since
6/27/2022
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 50 MG CAPSULE has been published 154 times since Jul 19, 2023, and over the history we have for it it has declined 45.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1463 per EA |
|---|---|
| All-time high | $0.2848 (Mar 13, 2024) |
| All-time low | $0.1165 (Nov 20, 2024) |
| 52-week high | $0.1798 |
| 52-week low | $0.1441 |
| Median price | $0.1744 |
| Average price | $0.1864 |
| Largest weekly change | -37.5% (Nov 20, 2024) |
| Weeks tracked | 154 |
| Tracking since | Jul 19, 2023 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DOXEPIN 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 50 MG CAPSULE, manufactured by Novadoz Pharmaceuticals LLC, is $0.1463 per EA (NDC 72205009091), effective Jun 24, 2026.
How has the price of DOXEPIN 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 50 MG CAPSULE has declined 45.8%. It has been tracked across 154 weekly CMS publications since Jul 19, 2023.
What are the highest and lowest recorded NADAC prices for DOXEPIN 50 MG CAPSULE?
Since Jul 19, 2023, the NADAC for DOXEPIN 50 MG CAPSULE has ranged from a low of $0.1165 (Nov 20, 2024) to a high of $0.2848 (Mar 13, 2024), with a median of $0.1744 per EA.
Are there cheaper alternatives to DOXEPIN 50 MG CAPSULE?
7 NADAC-published products share the same active ingredient, strength, and dosage form as DOXEPIN 50 MG CAPSULE, but none are currently priced below it.
Who manufactures DOXEPIN 50 MG CAPSULE?
DOXEPIN 50 MG CAPSULE (NDC 72205009091) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification